KAITLYN PIERCE: Open Payments
NPI 1790243582 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,574 in 75 payments from 21 companies in 2025. Trend: 2023 $1,530 · 2024 $903 · 2025 $1,574
Food & beverage: $1,399Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $232 |
| Amgen Inc. | 5 | $226 |
| ABBVIE INC. | 15 | $225 |
| Lundbeck LLC | 10 | $170 |
| AstraZeneca Pharmaceuticals LP | 9 | $165 |
| Axsome Therapeutics, Inc. | 5 | $105 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $80 |
| PFIZER INC. | 4 | $80 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| HARMONY BIOSCIENCES LLC | 1 | $27 |
Products named: VRAYLAR, REXULTI, PROLIA, Ozempic, Auvelity, BREZTRI, Kerendia, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
